- Home
- ONCO vs STRR Comparison
ONCO vs STRR Comparison
Compare ONCO & STRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCO
- STRR
- Stock Information
- Founded
- ONCO 2018
- STRR 1985
- Country
- ONCO United States
- STRR United States
- Employees
- ONCO N/A
- STRR N/A
- Industry
- ONCO Biotechnology: Pharmaceutical Preparations
- STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ONCO Health Care
- STRR Health Care
- Exchange
- ONCO Nasdaq
- STRR Nasdaq
- Market Cap
- ONCO 1.8M
- STRR 6.3M
- IPO Year
- ONCO 2022
- STRR N/A
- Fundamental
- Price
- ONCO $4.70
- STRR $2.03
- Analyst Decision
- ONCO
- STRR Strong Buy
- Analyst Count
- ONCO 0
- STRR 1
- Target Price
- ONCO N/A
- STRR $5.00
- AVG Volume (30 Days)
- ONCO 232.8K
- STRR 21.6K
- Earning Date
- ONCO 06-12-2025
- STRR 08-12-2025
- Dividend Yield
- ONCO N/A
- STRR N/A
- EPS Growth
- ONCO N/A
- STRR N/A
- EPS
- ONCO N/A
- STRR N/A
- Revenue
- ONCO $1,925,313.00
- STRR $57,165,000.00
- Revenue This Year
- ONCO N/A
- STRR $33.64
- Revenue Next Year
- ONCO N/A
- STRR $22.87
- P/E Ratio
- ONCO N/A
- STRR N/A
- Revenue Growth
- ONCO 153.70
- STRR 34.33
- 52 Week Low
- ONCO $3.82
- STRR $1.72
- 52 Week High
- ONCO $1,190.00
- STRR $5.35
- Technical
- Relative Strength Index (RSI)
- ONCO 42.32
- STRR 44.94
- Support Level
- ONCO $4.40
- STRR $1.95
- Resistance Level
- ONCO $5.10
- STRR $2.02
- Average True Range (ATR)
- ONCO 0.71
- STRR 0.07
- MACD
- ONCO 0.05
- STRR -0.00
- Stochastic Oscillator
- ONCO 25.84
- STRR 29.61
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
About STRR Star Equity Holdings Inc.
Star Equity Holdings Inc is a multi-industry diversified holding company. It operates in two segments: Building Solutions segment, through KBS, EBGL and TT, it services residential and commercial construction projects by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, other engineered wood products, and supply general contractors with building materials; and Investments segment, which holds corporate-owned real estate, currently includes one manufacturing facility and the equipment for another manufacturing facility in Maine that it leases back to KBS and its manufacturing facility in Wisconsin that it leases back to TT. The company derives maximum revenue from Building Solutions Segment.